Circulating cell-free DNA is a predictor of short-term neurological outcome in stroke patients treated with intravenous thrombolysis

Circulating cell-free DNA (cfDNA) has been described as a prognostic marker for several diseases. Its prognostic value for short-term outcome in stroke patients treated with intravenous thrombolysis remains unexplored. cfDNA was measured on admission in 54 tissue plasminogen activator (tPA)-treated...

Descripción completa

Detalles Bibliográficos
Autores principales: Bustamante, Alejandro, Mancha, Fernando, Macher, Hada C, García-Berrocoso, Teresa, Giralt, Dolors, Ribó, Marc, Guerrero, Juan M, Montaner, Joan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5548318/
https://www.ncbi.nlm.nih.gov/pubmed/28936264
http://dx.doi.org/10.1177/1849454416668791

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5548318/
https://www.ncbi.nlm.nih.gov/pubmed/28936264
http://dx.doi.org/10.1177/1849454416668791

Ejemplares similares